NAVLE Musculoskeletal

Feline Masticatory Muscle Myositis – NAVLE Study Guide

📅 March 28, 2026 ⏱ 20 min read

Overview and Clinical Importance

Masticatory Muscle Myositis (MMM) is an immune-mediated inflammatory myopathy that targets the muscles of mastication. While extensively documented in dogs, MMM has been considered rare or questioned to exist in cats. However, recent case reports have confirmed that feline MMM does occur, presenting with clinical signs of restricted jaw mobility (trismus) and masticatory muscle atrophy. The disease involves autoantibodies directed against unique type 2M muscle fibers found exclusively in the masticatory muscles.

Feline masticatory muscles, like their canine counterparts, contain type 2M fibers with a unique myosin isoform not present in limb muscles. This makes them a specific target for autoimmune attack. Early recognition and treatment are critical for a favorable outcome, as chronic cases may develop irreversible fibrosis and permanent jaw dysfunction.

High-YieldFeline MMM is extremely rare but should be included in the differential diagnosis for any cat presenting with trismus (inability to open the mouth) and masticatory muscle atrophy. The canine 2M antibody ELISA can cross-react with feline antibodies for diagnosis.

Muscle	Origin	Insertion	Function
Temporalis	Temporal fossa	Coronoid process of mandible	Jaw elevation and retraction
Masseter	Zygomatic arch	Lateral surface of mandibular ramus	Jaw elevation (primary)
Medial Pterygoid	Pterygoid fossa	Medial surface of mandibular ramus	Jaw elevation, lateral movement
Lateral Pterygoid	Lateral pterygoid plate	Mandibular condyle	Jaw protrusion, opening

Anatomy of Masticatory Muscles

The masticatory muscles are responsible for jaw movement and include four paired muscles. All are innervated by the mandibular branch of the trigeminal nerve (CN V3), except for the caudal belly of the digastricus, which is innervated by the facial nerve (CN VII).

Masticatory Muscles Summary

Type 2M Muscle Fibers: The Key to MMM

Masticatory muscles contain a unique myosin isoform called type 2M that is not present in limb or other skeletal muscles. This fiber type originates from branchial arch mesoderm (first pharyngeal arch), whereas limb muscles originate from paraxial mesoderm. The distinct embryological origin results in antigenically distinct muscle proteins.

In MMM, autoantibodies specifically target these type 2M fibers, leading to inflammation, phagocytosis, and myonecrosis. This explains why only the masticatory muscles are affected while limb muscles remain normal. T lymphocytes play a key role in the immune-mediated destruction.

NAVLE TipRemember that type 2M fibers are EXCLUSIVE to masticatory muscles. When a cat or dog has muscle atrophy or dysfunction limited to the jaw muscles with sparing of limb muscles, think MMM. Limb muscle involvement would suggest polymyositis or generalized myopathy instead.

Phase	Pathology	Clinical Presentation
Acute	Inflammation, lymphocytic-plasmacytic infiltration, eosinophils, myofiber necrosis and phagocytosis	Swollen, painful masticatory muscles; trismus; exophthalmos; fever; third eyelid protrusion
Chronic	Progressive fibrosis, myofiber loss and atrophy, decreased inflammation	Severe bilateral muscle atrophy; persistent trismus; enophthalmos (from muscle wasting); no pain
End-Stage	Extensive fibrosis with minimal remaining muscle fibers; irreversible changes	Permanent jaw restriction; poor response to treatment; may maintain body condition if fed soft food

Pathophysiology

The exact etiology of MMM remains unknown, but it is an autoimmune disorder with circulating antibodies directed against type 2M myofibers. Proposed mechanisms include:

Molecular mimicry: Cross-reactivity between bacterial antigens and type 2M myosin
Myositigen antibodies: Antibodies against masticatory muscle-specific myosin binding protein C family members
T-cell mediated destruction: Lymphocytic infiltration targeting 2M fibers

Disease Phases

Test	Expected Findings	Clinical Significance
CBC	Eosinophilia (mild), possible mild nonregenerative anemia	Non-specific; eosinophilia supports inflammatory process
Serum Chemistry	Elevated CK (creatine kinase), elevated AST, elevated globulins	CK elevation indicates active muscle damage; may be normal in chronic phase
2M Antibody Titer	Positive (greater than 1:100 using canine ELISA)	100% specific, 85-90% sensitive; false negatives in end-stage or immunosuppressed patients
Skull Radiography	Usually normal; rules out bony abnormalities	Excludes TMJ disease, fractures, neoplasia
CT Scan	Bilateral symmetric masticatory muscle atrophy; no TMJ abnormalities	Rules out osseous causes of trismus; documents muscle changes
MRI	T2W/STIR hyperintensity in muscles; contrast enhancement; areas of necrosis/fluid	Most sensitive imaging; guides biopsy site; monitors treatment response
EMG	Abnormal spontaneous activity in masticatory muscles (may be normal in some cats)	Sensitive but not specific; helps localize disease to masticatory muscles vs polymyositis
Muscle Biopsy	Lymphocytic-plasmacytic infiltration, 2M fiber necrosis, fibrosis (chronic), eosinophils	Gold standard for diagnosis; provides prognostic information based on fibrosis extent

Clinical Presentation in Cats

Feline MMM is exceptionally rare, with only a handful of documented cases in the veterinary literature. The clinical presentation parallels canine MMM but may be more challenging to detect due to cats' tendency to conceal pain and their independent nature. Key presentations include:

Acute Phase Signs

Facial swelling: Generalized swelling of the head extending to neck and cheeks
Ocular signs: Exophthalmos (bilateral), third eyelid protrusion, conjunctival hyperemia, chemosis
Trismus: Inability or reduced ability to open the mouth
Pain: Pain on palpation of masticatory muscles or when opening the mouth
Systemic signs: Fever, lymphadenopathy, lethargy, decreased appetite

Chronic Phase Signs

Muscle atrophy: Severe, bilateral, symmetrical atrophy of temporalis and masseter muscles
Restricted jaw motion: Persistent limited vertical mandibular range of motion (normal cat: approximately 62 mm mean)
Enophthalmos: Sunken eyes due to loss of retrobulbar muscle mass
Difficulty eating: Slow eating, preference for soft food, difficulty prehending food

High-YieldFeline MMM may go undetected longer than canine MMM due to: (1) long haircoats obscuring muscle atrophy, (2) cats concealing oral pain, (3) cats not engaging in oral play behavior, and (4) owners not closely monitoring jaw function. A cat can maintain body condition with only 11-12 mm jaw opening by licking soft food.

Condition	Key Differentiating Features	Diagnostic Test
TMJ Ankylosis/Fracture	History of trauma; bony changes on imaging; may have crepitus	CT scan of skull/TMJ
Retrobulbar Abscess/Mass	Often unilateral; swelling behind carnassial tooth; drainage	Oral exam, CT/MRI, cytology
Trigeminal Neuritis	Dropped jaw (inability to close); non-painful; flaccid jaw tone	Clinical presentation, EMG
Polymyositis	Generalized muscle weakness; limb muscles also affected	2M antibody negative; biopsy of limb muscles
Neoplasia	May be asymmetric; lymph node involvement; bone lysis possible	Imaging, biopsy, cytology
Tetanus	Generalized muscle rigidity; risus sardonicus; history of wound	Clinical diagnosis; history
Fibrodysplasia Ossificans	Heterotopic bone formation in muscles; progressive	CT (mineralization); histopathology

Diagnostic Approach

Diagnosis of feline MMM requires a combination of clinical findings, laboratory testing, imaging, and histopathology. Early and accurate diagnosis is essential for optimal treatment response.

Diagnostic Tests Summary

2M Antibody Test: Key Points

The serum 2M antibody test is available through the Comparative Neuromuscular Laboratory at UC San Diego. Since no feline-specific assay exists, the canine ELISA is used to detect cross-reacting antibodies against type 2M muscle fiber proteins.

Reference interval: Less than 1:100 in dogs and normal cats
Positive results: Titers of 1:500 to 1:4000 have been documented in affected cats
False negatives: May occur in end-stage disease (all 2M fibers destroyed) or with prior corticosteroid therapy
Monitoring: Can be used to detect subclinical relapses and guide therapy tapering

NAVLE TipFor NAVLE, remember that the 2M antibody titer is 100% SPECIFIC but only 85-90% SENSITIVE. A positive test confirms MMM, but a negative test does not rule it out, especially in chronic cases or patients on steroids. When in doubt, proceed with muscle biopsy.

Histopathologic Findings

Muscle biopsy from the temporalis muscle is the gold standard for diagnosis. The biopsy should be submitted to a specialized neuromuscular laboratory for proper evaluation. Key findings include:

Acute Phase Histopathology

Multifocal lymphocytic-plasmacytic perivascular infiltration
Eosinophils (occasional)
Necrosis and phagocytosis of type 2M myofibers
Mononuclear cell infiltrations with endomysial and perimysial distribution

Chronic Phase Histopathology

Marked myofiber loss with extensive fibrosis
Remaining myofibers are atrophic
Decreased inflammatory infiltrates
Internal nuclei in regenerating fibers

Phase	Drug and Dose	Duration and Notes
Induction	Prednisolone 2-4 mg/kg PO q24h	Continue until jaw function returns to normal or plateaus (usually 2-4 weeks)
Tapering	Decrease by 25-50% every 4-6 weeks	Monitor 2M titers before each reduction; total treatment 6-12 months minimum
Maintenance	Lowest effective dose (0.5-1 mg/kg q48h or less)	May require long-term or lifelong therapy; some cats may be weaned completely
Relapse/Adjunct	Ciclosporin 4-5 mg/kg PO q12h (add to prednisolone)	For steroid-refractory cases or to reduce steroid side effects; monitor for DM

Differential Diagnosis

When evaluating a cat with trismus or masticatory muscle atrophy, consider the following differential diagnoses:

Stage at Diagnosis	Prognosis
Acute (early)	Good to excellent with prompt treatment; 90% of dogs regain normal jaw function within 2-3 months; expected similar in cats
Chronic (moderate fibrosis)	Fair; some improvement possible but complete resolution unlikely; may have permanent jaw restriction
End-stage (severe fibrosis)	Poor for functional recovery; permanent trismus; can maintain quality of life with dietary modification

Treatment

Treatment of feline MMM parallels the approach used in dogs, focusing on immunosuppressive therapy with corticosteroids as first-line treatment. Early, aggressive treatment offers the best prognosis.

Treatment Protocol

Important Treatment Considerations

Do NOT forcibly open the jaw: Risk of iatrogenic fracture or soft tissue damage
Rule out infectious causes before steroids: Toxoplasma, bacterial, or fungal myositis
Nutritional support: Soft or liquid food during acute phase; cats can eat with minimal jaw opening
Monitor for relapses: Approximately 25% of dogs relapse; rate unknown in cats
Monitor for steroid side effects: Diabetes mellitus is a significant concern with chronic use in cats

High-YieldEarly treatment is KEY! Once significant fibrosis develops (chronic/end-stage MMM), jaw mobility may not improve regardless of treatment. The prognosis depends on the degree of fibrosis present at diagnosis. Always perform a muscle biopsy to assess fibrosis extent for prognostic purposes.

Prognosis

Memory Aid

MMM = "Muscles of Mastication + Myositis" 2M Fibers: Only in Masticatory Muscles (Temporalis, Masseter, pterygoids) 2M Test: 100% Specific, 85% Sensitive Trismus = Think MMM first in cats with locked jaw + muscle atrophy Treatment = Immunosuppressive steroids for 6-12 months minimum

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →

Feline Masticatory Muscle Myositis &ndash; NAVLE Study Guide